FDA approves 1st new drug for schizophrenia in more than 30 years
The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...
F.D.A. Approves the First New Schizophrenia Drug in Decades
Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.
verywellhealth9d
Cobenfy: The First New Schizophrenia Drug in Decades
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
FiercePharma2d
For Bristol Myers Squibb's newly approved schizophrenia drug, what a long, strange trip it's been
Off the scrapheap of discarded drugs and on its way to becoming the most highly anticipated approval of 2024, Bristol Myers ...
This FDA-approved drug promises a new way to treat schizophrenia
Bristol Myers Squibb's drug, KarXT, improved symptoms of adults with schizophrenia and had fewer side effects than antipsychotic treatments ...
Bristol Myers wins US FDA approval for new type of schizophrenia drug
The U.S. Food and Drug Administration approved Bristol Myers Squibb's schizophrenia drug late on Thursday, making it the ...
Boise State Public Radio12d
A new kind of drug for schizophrenia promises fewer side effects
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
WebMD13d
FDA Approves Revolutionary Schizophrenia Drug
the medication, which will be marketed under the name Cobenfy, targets a different pathway in the brain, offering new hope for treatment. Schizophrenia is a serious mental disorder that affects ...
USA Today12d
This FDA-approved drug promises a new way to treat schizophrenia
People with schizophrenia will have a new treatment ... Bristol Myers Squibb will sell the drug combination under the brand name Cobenfy. The pharmaceutical company hasn't said how much it will ...
ABC News13d
FDA approves 1st new drug for schizophrenia in more than 30 years
The medication, Cobenfy, combines two drugs and is taken as a twice-daily pill. The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with ...